CompletedPhase 3NCT00002700
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
Studying Acute lymphoblastic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Principal Investigator
- Roel Willemze, MD, PhDLeiden University Medical Center
- Intervention
- asparaginase(drug)
- Enrollment
- 392 enrolled
- Eligibility
- 15-60 years · All sexes
- Timeline
- 1995
Study locations (30)
- Algemeen Ziekenhuis Middelheim, Antwerp, Belgium
- A.Z. St. Jan, Bruges, Belgium
- C.H.U. Saint-Pierre, Brussels, Belgium
- Hopital Universitaire Erasme, Brussels, Belgium
- Universitair Ziekenhuis Antwerpen, Edegem, Belgium
- CHU Sart-Tilman, Liège, Belgium
- Centre Hospitalier Peltzer-La Tourelle, Verviers, Belgium
- University Hospital Rebro, Zagreb, Croatia
- Medical School/University of Zagreb, Zagreb (Agram), Croatia
- University Hospital - Olomouc, Olomouc, Czechia
- Hopital Edouard Herriot, Lyon, France
- Hotel Dieu de Paris, Paris, France
- Hopital Necker, Paris, France
- Centre Medico-Chirurgical Foch, Suresnes, France
- Kreiskrankenhaus Meissen, Meissen, Germany
- +15 more locations on ClinicalTrials.gov
Collaborators
Acute Leukemia French Association
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00002700 on ClinicalTrials.govOther trials for Acute lymphoblastic leukemia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05621291A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...National Cancer Institute (NCI)
- RECRUITINGPHASE2NCT06738368Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaUniversity of Washington
- ENROLLING BY INVITATIONNCT07511959Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative DentistryWroclaw Medical University
- RECRUITINGNANCT07191119Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic LeukemiaSt. Jude Children's Research Hospital
- RECRUITINGNANCT07177183Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning FailureUniversity Hospital Ostrava
- RECRUITINGPHASE2NCT07275762Y-4 to Treat the Postherpetic NeuralgiaNeurodawn Pharmaceutical Co., Ltd.
- ENROLLING BY INVITATIONNCT07515430The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic LeukemiaSun Yat-sen University
- RECRUITINGNANCT07201974Virtual Reality for Post-Stroke Gait RehabilitationMcGill University